CARE Ratings Allots 1,850 Equity Shares Under Employee Stock Option Scheme 2020

1 min read     Updated on 07 Apr 2026, 12:39 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

CARE Ratings Limited has allotted 1,850 equity shares to employees under its Employee Stock Option Scheme 2020, as approved by the Nomination and Remuneration Committee on April 06, 2026. The shares, with a face value of Rs.10/- each, increased the company's paid-up share capital from Rs. 30,04,70,130/- to Rs. 30,04,88,630/-. The total number of equity shares rose from 3,00,47,013 to 3,00,48,863 shares following this allotment.

powered bylight_fuzz_icon
37048196

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited has completed the allotment of 1,850 equity shares to its employees under the CARE Employee Stock Option Scheme 2020. The company informed the stock exchanges about this development through a regulatory filing dated April 06, 2026.

ESOP Allotment Details

The Nomination and Remuneration Committee of the Board of Directors approved the allotment of equity shares pursuant to the exercise of employee stock options. The allotment specifics are outlined below:

Parameter: Details
Number of Shares Allotted: 1,850 equity shares
Face Value per Share: Rs.10/-
Share Status: Fully paid up
Scheme: CARE Employee Stock Option Scheme 2020
Approval Date: April 06, 2026

Impact on Share Capital

The allotment has resulted in an increase in the company's paid-up share capital. The capital structure change is detailed in the following comparison:

Metric: Before Allotment After Allotment Change
Paid-up Share Capital: Rs. 30,04,70,130/- Rs. 30,04,88,630/- Rs. 18,500/-
Number of Equity Shares: 3,00,47,013 shares 3,00,48,863 shares 1,850 shares
Face Value per Share: Rs.10/- each Rs.10/- each No change

Regulatory Compliance

The company has duly informed both major stock exchanges about this corporate action. CARE Ratings is listed on BSE Limited with scrip code 534804 and on The National Stock Exchange of India Limited with scrip code CARERATING. The notification was signed by Manoj Kumar CV, Company Secretary & Compliance Officer, ensuring proper regulatory compliance under the applicable listing regulations.

This ESOP exercise reflects the company's commitment to employee participation in its growth through equity-based compensation schemes. The allotment was executed in accordance with the established Employee Stock Option Scheme 2020 framework.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
-1.69%+2.73%-5.06%+3.80%+36.74%+244.12%

How many more employee stock options remain unexercised under the CARE Employee Stock Option Scheme 2020?

Will CARE Ratings expand its ESOP program or introduce new employee incentive schemes in the upcoming fiscal year?

What impact might this employee equity participation have on CARE Ratings' talent retention strategy in the competitive credit rating industry?

CARE Ratings Limited Announces Chief Technology Officer Transition

1 min read     Updated on 01 Apr 2026, 11:25 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

CARE Ratings Limited announced the resignation of Chief Information and Technology Officer Mr. Nadir Bhalwani effective March 31, 2026, due to personal reasons, and the appointment of Dr. A Shiju Rawther as new CTO from April 1, 2026. Dr. Rawther brings over 23 years of technology leadership experience and has previously worked with SBI Funds Management Limited, Poonawalla Finance, IIFL Finance Limited, and WIPRO Limited. He holds a PhD in Computer Science and Engineering and specializes in digital transformation, business process re-engineering, and aligning technology strategy with business priorities.

powered bylight_fuzz_icon
36568529

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited has announced a leadership transition in its technology department, with the resignation of its Chief Information and Technology Officer and the appointment of a new CTO effective April 1, 2026.

Leadership Transition Details

The company disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that Mr. Nadir Bhalwani ceased to be Chief Information and Technology Officer effective March 31, 2026, due to personal reasons. In his resignation communication, Bhalwani expressed appreciation for the support and guidance received during his tenure and wished the organization continued success.

Position: Details
Outgoing CTO: Mr. Nadir Bhalwani
Cessation Date: March 31, 2026
Reason: Personal reasons
New CTO: Dr. A Shiju Rawther
Appointment Date: April 1, 2026

New CTO Profile and Experience

Dr. A Shiju Rawther has been appointed as the new Chief Information and Technology Officer with effect from April 1, 2026. He brings extensive academic credentials and professional experience to the role.

Educational Background

  • PhD in Computer Science and Engineering from Hindustan Institute of Technology & Science, Chennai, India
  • Bachelor of Engineering in Computer Science & Engineering from Bangalore University

Professional Experience

Dr. Rawther is a technology leader with over 23 years of diversified experience in leading technology and operations teams. His expertise spans several key areas:

  • Digital transformation initiatives
  • Business process re-engineering
  • Aligning technology strategy with business priorities
  • Enhancing customer experience
  • P&L Management for both large companies and startups
Previous Organizations: Role Focus
SBI Funds Management Limited: Technology Leadership
Poonawalla Finance: Operations Management
IIFL Finance Limited: Digital Transformation
WIPRO Limited: Technology Strategy

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of the SEBI Listing Regulations, with the company providing detailed disclosures as required under Schedule III. The communication was signed by Manoj Kumar CV, Company Secretary & Compliance Officer, and submitted to both BSE Limited and The National Stock Exchange of India Limited.

This seamless transition ensures continuity in the company's technology leadership, with Dr. Rawther's extensive experience expected to support the organization's digital transformation and technology strategy initiatives.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
-1.69%+2.73%-5.06%+3.80%+36.74%+244.12%

What specific digital transformation initiatives might Dr. Rawther prioritize given his experience with fintech companies like IIFL Finance and Poonawalla Finance?

How could this leadership change impact CARE Ratings' technology roadmap and competitive positioning in the credit rating industry?

Will Dr. Rawther's P&L management experience signal a shift toward more technology-driven revenue streams for CARE Ratings?

More News on CARE Ratings

1 Year Returns:+36.74%